The CYP39A1 gene helps the liver break down a cholesterol-related substance made in the brain, which helps your body clear it. This gene plays an important role in keeping this process balanced. If it does not work well, that substance can build up, and rare inherited variants have been linked to a form of ataxia, which can cause unsteady walking and poor coordination.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some hold the information needed to produce proteins, the parts of cells that do much of the work. Others mainly guide when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
CYP39A1Gene function
What if the gene works
The CYP39A1 gene helps your body break down certain cholesterol byproducts, especially one made in the brain. This supports bile acid production and helps clear extra cholesterol through the liver.
Risk
What if the gene does not work
Variants in the CYP39A1 gene can mildly reduce or more strongly disrupt breakdown of 24-hydroxycholesterol, a cholesterol byproduct. This may change how cells handle this molecule and related bile acid pathways.
Treatment
What does that mean for your treatment
No CYP39A1-specific treatment or management approach is currently established in clinical guidelines. The CYP39A1 gene is being studied in brain cholesterol pathways and as a possible biomarker in some cancers, but this has not changed routine treatment choices.
Gene function
What if the gene works
Your body uses the CYP39A1 gene to process a specific cholesterol byproduct called 24S-hydroxycholesterol. This helps move used cholesterol out of the brain and prepares it for further breakdown, mainly in the liver. Understanding what the CYP39A1 gene does in the body helps show how normal cholesterol turnover stays balanced from day to day.
This gene helps your cells change 24S-hydroxycholesterol, a form that carries extra cholesterol away from the brain, into a form that can be processed further. This supports steady day to day cholesterol turnover.
By working on 24S-hydroxycholesterol, its protein supports the normal route that moves used cholesterol from the brain toward liver processing. This helps connect brain cholesterol renewal with the body's wider cleanup system.
Its protein carries out a step in a cholesterol breakdown pathway linked to bile acid production. Bile acids help digest fats, and this pathway is one way the body manages cholesterol after it has been used.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP39A1 gene can alter the enzyme’s shape, stability, or amount, so cells may process 24-hydroxycholesterol, a cholesterol byproduct, less efficiently. Some changes have only a mild effect, while more disruptive variants can sharply reduce activity, cause the enzyme to fold poorly, or stop it from being made. This is the main way CYP39A1 gene variants affect enzyme activity in cells.
How variants are linked to conditions
Research on conditions linked to CYP39A1 gene variants is still developing, and no specific health condition has a broadly confirmed association at this time. Anyone with a confirmed CYP39A1-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some cases, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CYP39A1 gene. If CYP39A1 is part of your test results and you want to understand what it may mean for you or your family, a doctor or genetic counselor can help put it in context.
Inheritance of CYP39A1 variants
There is not yet a broadly confirmed disease specific CYP39A1 inheritance pattern in human genetics, so how CYP39A1 variants are inherited is not tied to one well established dominant, recessive, or X linked condition. The CYP39A1 gene is located on chromosome 6, which is an autosome. That means you inherit one copy from your mother and one copy from your father.
What does my CYP39A1 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific health condition for the CYP39A1 gene, although this may become clearer as research grows. If you have a specific CYP39A1 result and want to know what it could mean for close relatives, a doctor or genetic counselor can help explain it in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
CYP39A1 genetic testing shows how to test for CYP39A1 variants using DNA from a blood or saliva sample. A lab reads the CYP39A1 gene, often as part of a larger panel or exome test, and compares the sequence with a reference to identify and classify any variant.
When should I consider getting a genetic test?
There isn't yet a broadly established, CYP39A1-specific reason for genetic testing in routine care. Testing decisions are best made with a doctor or genetic counselor, based on your symptoms, family history, and the reason testing is being considered.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and on the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than others, so the same treatment may work differently from one person to the next. This is a common part of human biology and can influence how much benefit a medicine gives or how sensitive someone is to side effects. Medication response also depends on other factors, including age, liver and kidney function, and other medicines you take.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way people respond to medications. It studies gene drug relationships to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support treatment choices that are more informed and more personalized. To look into this subject further, more information is available in the LearnHub.
Drugs influenced by the CYP39A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about side effects, poor symptom control, or how medicines fit with your overall health are best discussed with your doctor or pharmacist.
History
The CYP39A1 gene entered the scientific literature in the late 1990s, when researchers were mapping and comparing members of the cytochrome P450 family. Initially understood only through visible traits, later recognized as tied to a specific gene, this work helped place CYP39A1 among enzymes active in cholesterol related pathways. From these first observations, research expanded steadily as scientists cloned the gene and described where it is active in the body, especially in the liver and brain. Its history has mostly unfolded through laboratory and biochemistry studies rather than public awareness campaigns. Over time, descriptions became more precise as genetic databases and sequencing projects clarified the gene’s structure and chromosomal location.